AKT1S1
Proline-rich AKT1 substrate 1
Also known as: AKTS1_HUMAN, Lobe, MGC2865, PRAS40
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96B36
- Gene
- AKT1S1
- Ensembl
- ENSG00000204673
- Chromosome
- 19
- Canonical length
- 256 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
AKT1S1 is a proline-rich substrate of AKT (MIM 164730) that binds 14-3-3 protein (see YWHAH, MIM 113508) when phosphorylated (Kovacina et al., 2003 [PubMed 12524439]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
256 residues, UniProt reviewed canonical sequence.
>Q96B36|AKT1S1
1 MASGRPEELW EAVVGAAERF RARTGTELVL LTAAPPPPPR PGPCAYAAHG RGALAEAARR
61 CLHDIALAHR AATAARPPAP PPAPQPPSPT PSPPRPTLAR EDNEEDEDEP TETETSGEQL
121 GISDNGGLFV MDEDATLQDL PPFCESDPES TDDGSLSEET PAGPPTCSVP PASALPTQQY
181 AKSLPVSVPV WGFKEKRTEA RSSDEENGPP SSPDLDRIAA SMRALVLREA EDTQVFGDLP
241 RPRLNTSDFQ KLKRKYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AKT1S1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 113 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 113 nTPM
- liver: 62 nTPM
- esophagus: 51 nTPM
- skin: 51 nTPM
- adrenal gland: 51 nTPM
- heart muscle: 44 nTPM
Single-cell type
- respiratory ionocytes: 5.1 nCPM
- syncytiotrophoblasts: 3 nCPM
- thymic myoid cells: 2.7 nCPM
- epicardial cells: 2.3 nCPM
- late spermatids: 2 nCPM
- parietal cells: 1.8 nCPM
Immune cell
- neutrophil: 1.7 nTPM
- non-classical monocyte: 1.6 nTPM
- intermediate monocyte: 1.4 nTPM
- plasmacytoid DC: 1.2 nTPM
- classical monocyte: 1.1 nTPM
- T-reg: 1 nTPM
Brain region
- midbrain: 58 nTPM
- medulla oblongata: 56 nTPM
- pons: 56 nTPM
- thalamus: 52 nTPM
- white matter: 50 nTPM
- basal ganglia: 49 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.83
- gnomAD pLI
- 0.11
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of cell size
- negative regulation of protein kinase activity
- negative regulation of TOR signaling
- negative regulation of TORC1 signaling
- neurotrophin TRK receptor signaling pathway
- regulation of apoptotic process
- regulation of neuron apoptotic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Proline-rich AKT1 substrate 1 protein
- Proline-rich AKT1 substrate 1, N-terminal domain
- Proline-rich AKT1 substrate 1
- Proline-rich AKT1 substrate 1, N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AKT1S1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AKT1S1 as an antibody target. Whether an autoantibody or antibody against AKT1S1 could matter depends on whether native AKT1S1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AKT1S1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AKT1S1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...